Hollings Renton

Hollings Chase Renton currently works at AnaptysBio, Inc., as Lead Independent Director and Zymeworks BC, Inc., as Director from 2017.
Mr. Renton also formerly worked at Onyx Pharmaceuticals, Inc., as Chairman, President & Chief Executive Officer from 2000 to 2008, Portola Pharmaceuticals LLC, as Chairman from 2015 to 2020, SangStat Medical Corp., as Director, Rigel Pharmaceuticals, Inc., as Independent Director from 2011 to 2014, CEPHEID, as Director from 2000 to 2016, Genzyme Corp., as Director, Kythera Biopharmaceuticals LLC, as Independent Director from 2014 to 2015, Biotechnology Innovation Organization, as Director, Affymax, Inc., as Director from 2009 to 2014, Special Olympics of Northern California, as Director, Zymeworks, Inc., as Independent Director from 2017 to 2024, Chiron Corp., as President & Chief Operating Officer from 1991 to 1993, and Cetus Corp., as President from 1990 to 1991.
Mr. Renton received his undergraduate degree from Colorado State University and Masters Business Admin degree from the University of Michigan.